Abivax S.A.
ABVX News Today: Stay Updated with the Latest Abivax S.A. News in Real Time
Find ABVX news now at Meyka AI. Stay informed with the latest Abivax S.A. stocks updates, including price news, market analysis, and expert insights.
ABVX.PA ABIVAX SA (EURONEXT) -10.97% after hours 24 Mar 2026: catalysts ahead
ABVX.PA stock fell 10.97% after hours to EUR 97.40; analysis, Meyka AI grade and forecasts for investors.
Pre-market top loser: IPH.PA Innate Pharma €1.15 on 21 Mar 2026: earnings risk ahead
IPH.PA stock falls to €1.15 pre-market on 21 Mar 2026; analysis, grade, and Meyka AI forecast for near-term downside and catalysts
€107.40 ABVX.PA stock pre-market: earnings due Mar 23 may reset targets
Pre-market look at ABVX.PA stock ahead of Mar 23 earnings; price, forecasts, Meyka grade and analyst targets
ALMDP.PA Medesis Pharma EURONEXT €0.35 intraday Feb 19 2026: Oversold bounce
Intraday oversold bounce analysis of ALMDP.PA stock at €0.35 on EURONEXT on 19 Feb 2026 with Meyka AI insights
Eli Lilly Set to Make €15 Billion Offer for French Biotech Abivax, Report Says
Eli Lilly, one of the world’s biggest pharmaceutical companies, is reportedly preparing a €15 billion offer to acquire the French biotechnology firm Abivax SA, according to recent market reports. This potential deal reflects a strategic push by Eli Lilly to expand its presence in the biotech sector, tapping into cutting‑edge research and development pipelines that…